Impax Laboratories to Present at the 28th Annual J.P. Morgan Healthcare Conference
January 06 2010 - 10:00AM
Business Wire
Impax Laboratories, Inc. (NASDAQ:IPXL) today
announced that the Company will provide an update of the business
and 2010 financial outlook at the 28th Annual J.P. Morgan
Healthcare Conference on Monday, January 11th, at 4:00 p.m. Pacific
Standard time. The conference will be held at the Westin St.
Francis in San Francisco, CA.
Individuals may listen to the live or an archived presentation
made at the conferences, which will be posted in the investor
relations section of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30
days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing
partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward and Philadelphia
facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2024 to Jul 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2023 to Jul 2024